GAtherton

ABPA or Bronchiectasis? A Detailed Guide to Understanding Flare-Ups

Many people with allergic bronchopulmonary aspergillosis (ABPA) also live with bronchiectasis, and the symptoms can overlap so much that it’s difficult to know what’s flaring. This guide explains what is happening inside the lungs, the typical signs of each condition, and how to judge when to seek help.

1. What exactly happens during an ABPA flare?

ABPA is an allergic immune reaction to Aspergillus in the airways.
The fungus is usually present in tiny amounts, but the immune system over-reacts to it.

During a flare:

  • The immune system releases large amounts of inflammatory chemicals (especially IgE and eosinophils).

  • Airways become swollen, narrow and sticky.

  • Thick, glue-like mucus forms and can block off airway sections.

Typical symptoms of an ABPA flare

  • Increased wheeze, chest tightness or asthma-like symptoms

  • Shortness of breath, sometimes sudden

  • Very thick, sticky, tenacious sputum

  • Mucus plugs — sometimes shaped like soft tubes or “casts” of an airway

  • Drop in peak flow or lung function

  • IgE levels rising (but this may lag behind symptoms by days or weeks)

Colour of mucus in ABPA

  • Often golden-brown

  • Can be brown or even dark brown if old mucus is clearing

  • May contain small black dots (fungal elements) but this can also appear in bronchiectasis

2. What happens during a bronchiectasis flare?

Bronchiectasis is a structural lung condition. The airways are wider and more damaged, meaning mucus gets trapped more easily.

During a flare:

  • The airway lining becomes irritated or infected.

  • Mucus production increases.

  • Trapped mucus becomes a breeding ground for bacteria.

  • Breathing may be heavier simply because of mucus load.

Typical symptoms of a bronchiectasis flare

  • Increase in sputum volume

  • Change in sputum colour (yellow, green, brown)

  • Worsening cough

  • Feeling more tired, feverish, or run down

  • Chest tightness from mucus but not usually dramatic wheeze

  • No immediate change in IgE levels

Bronchiectasis and brown sputum

  • Brown sputum is common when old blood, dried mucus or debris is being cleared.

  • After a lung bleed, blood changes colour as it ages:

    • Fresh = bright red

    • 24–48 hours = dark red

    • After a few days = brown, tar-like, sticky

This often appears suddenly after you think everything has settled.

3. Comparing the two conditions side-by-side

Feature ABPA Flare Bronchiectasis Flare
Main cause Immune/allergic reaction to Aspergillus Infection, inflammation, mucus trapping
Breathing Sudden ↑ wheeze + breathlessness Heavy/chesty breathing, fatigue
Mucus amount Normal amount but very thick or plug-like More mucus than usual
Mucus colour Golden-brown, brown, plug-like Yellow, green, brown
Mucus plugs Common Possible but less typical
IgE Often rises (but may lag) Stable
Peak flow Drops significantly Mild change or no change
General wellbeing Often feel “inflamed” without infection symptoms More infection-like tiredness/malaise

4. Understanding brown sputum properly

Brown sputum doesn’t always mean ABPA.

It can be:

  • Old blood breaking loose

  • Dried mucus from bronchiectasis

  • A mixture of dried secretions and oxidised blood proteins

  • Debris from a recently cleared airway infection

This is why a single brown plug — especially after a bleed — is rarely a sign of ABPA on its own.

5. When you should ask for help

Contact your specialist if you notice any of these:

  • Several days of brown plugs or repeated mucus casts

  • Dramatically increased wheeze

  • Peak flow drop >20% from your baseline

  • Fever, chills, or sudden tiredness

  • Breathlessness that feels “different” from normal

  • A major change in your usual bronchiectasis pattern

  • New chest pain

Seek urgent help if:

  • You cough up fresh bright red blood

  • You feel suddenly very breathless

  • You cough up a large amount of blood-stained sputum

  • You have signs of severe infection (rigors, high fever, confusion)

6. And what about IgE?

IgE is helpful, but has limitations:

  • It rises slowly — sometimes days or weeks after symptoms appear.

  • It can stay stable at your “baseline” even when mild inflammation is happening.

  • A stable IgE level is reassuring, but it does not rule out a flare.

Think of IgE as a trend, not an immediate alarm light.

7. The real-world takeaway

  • Bronchiectasis = more mucus, infected/inflamed feeling, colour change.

  • ABPA = allergic response, wheeze, plugs, sudden breathing changes.

  • Brown sputum alone is not enough to diagnose either way.

  • After a bleed, brown sputum is expected for days as the airway clears.

Learning your own pattern takes time. Even experienced patients still contact their team if something feels wrong — and that’s always the safest approach.

by GAtherton

🌿 Why We All Need to Advocate for Ourselves as the NHS Faces Change and Pressure

A patient-friendly guide to staying safe and getting the care you need

The NHS is going through one of the most challenging periods in its history. Services are under pressure, staff are stretched, and backlogs remain high across nearly every speciality. None of this is the fault of patients or staff — it’s the reality of a system trying to do too much with too little.

In times like this, one thing becomes more important than ever:

⭐ Advocating for your own health.

Advocacy simply means speaking up when you need help, asking questions, and making sure your concerns are heard. It’s not about complaining or demanding; it’s about ensuring you get the support, information, and care you deserve.

Here’s why it matters — and how to do it safely and confidently.

🔍 1. Some things no longer happen automatically

With so many clinics running over capacity, routine tasks can be delayed or missed:

  • Follow-up appointments don’t always get booked

  • Test results aren’t always communicated quickly

  • Reviews may slip off the system

  • New medications sometimes aren’t monitored as closely as they should be

This isn’t because your team doesn’t care.
It’s because the system is stretched.

Advocating for yourself helps fill the gaps.

💬 2. Asking questions keeps you safer

If something is unclear — a result, a new medication, a change in symptoms, or a delay — asking for clarification is not only reasonable, it’s sensible.

Good questions to ask:

  • “When should my next review be?”

  • “Who do I contact if I have a problem?”

  • “What symptoms should I watch for?”

  • “Is there a plan for monitoring?”

Healthcare teams want patients to feel informed.
They would rather you ask than worry in silence.

📞 3. The NHS wants patients to raise concerns early

Early contact helps prevent:

  • deteriorations

  • emergency admissions

  • medication complications

  • worsening long-term conditions

Services rely on patients saying, “Something isn’t right.”
It’s an essential part of safe care, not an inconvenience.

🧭 4. The NHS is changing — and patients play a role in shaping care

Integrated Care Systems (ICS), value-based care, and new digital pathways are all evolving.
These changes aim to make care:

  • more personalised

  • more consistent

  • more focused on real outcomes

But during transitions, there are bumps in the road.

Patient feedback — including when something hasn’t worked — helps services identify where improvements are needed.

You are part of shaping that improvement.

❤️ 5. You deserve to be heard

Many patients worry about “bothering” the NHS.
But advocating for yourself is:

  • responsible

  • appropriate

  • encouraged

  • part of keeping long-term conditions well-managed

You are not asking for anything unreasonable.
You are simply making sure your health is looked after.

🌼 6. How to advocate confidently

Here are gentle, effective ways to speak up:

Be clear
“I haven’t had a review since starting this treatment — can we arrange one?”

Be specific
“I’m unsure who to contact if I worsen. Could you give me the correct number?”

Be persistent if needed
“It’s been a few weeks since I asked — could you update me on the appointment?”

Keep records
Dates, names, symptoms, and messages help everything run more smoothly.

Ask for your named clinician or team
Every patient is entitled to know who oversees their care.

🌟 7. You are not alone — and it’s OK to ask for help

Advocacy doesn’t mean you carry the burden alone.
Groups like NAC, patient communities, and charities can help you:

  • understand the system

  • find the right contacts

  • prepare questions

  • know what to expect

  • get support if you’re struggling to be heard

Empowering yourself helps others too — the more patients speak up, the more the system adapts.

💚 In summary

The NHS is still full of dedicated people who care deeply about their patients.
But the reality of high demand and limited capacity means:

We all have to be a little more active in asking for what we need.

Advocating for your own health is:

  • responsible

  • protective

  • empowering

  • part of modern healthcare

It ensures you get the right care at the right time — and it helps the NHS deliver safer, more responsive services.

by GAtherton

🌲 Why Rough-Cut Wood Arrives Mouldy — and How to Reduce the Risk (Important for Aspergillosis Patients)

For anyone living with aspergillosis, ABPA, bronchiectasis or asthma, mould exposure can trigger symptoms or flares. Recently, several patients have reported that rough-cut timber is arriving mouldy from DIY suppliers, sawmills, or timber merchants.

Here’s why this happens — and what suppliers should be doing to prevent it.

⭐ Why rough-cut wood gets mouldy (especially in the UK)

Mould grows on timber whenever three conditions are present:

  1. Moisture

  2. Poor airflow

  3. Warm or humid air

Rough-cut timber is especially vulnerable because:

  • its uneven surface holds moisture,

  • it is often stacked tightly,

  • it may not be dried properly,

  • and UK weather (rain + high humidity) encourages mould.

Many suppliers wrap wood in plastic, which traps condensation during transport. This can create a humid “greenhouse” around the timber — perfect for mould growth in only 24–48 hours.

⭐ What UK suppliers should be doing (even for low-cost timber)

These are standard industry practices in UK timber yards and sawmills. None of them require wood to be kiln-dried (which is more expensive).

✔ 1. Air-dry properly (“sticker stacking”)

Boards must be stacked with spacers (“stickers”) between them so air can circulate.
No airflow = mould.

✔ 2. Store under cover, not outside in the rain

A simple open-sided shelter is enough.
Rain-soaked timber nearly always grows mould in transit.

✔ 3. Use breathable wrapping — NOT plastic sheeting

Plastic traps moisture.
Breathable paper wrap or perforated cover prevents condensation build-up.

✔ 4. Apply anti-fungal dip (borate)

Most UK sawmills use anti-mould dips to prevent blue-stain and mould during storage.
This costs pennies per board.

✔ 5. Moisture-test before delivery

A good supplier will check wood is below 20–22% moisture before dispatch.
Wet wood + UK weather = guaranteed mould.

⭐ Kiln drying is not essential

Kiln-dried timber is more expensive because it uses energy, equipment, and time to force-dry the wood.

But you do not need kiln-dried timber to avoid mould.

You simply need a supplier who:

  • stores the timber properly,

  • allows airflow,

  • avoids plastic,

  • and checks moisture before delivery.

If rough-cut wood is arriving mouldy, it usually means these steps were not followed.

⭐ What you can do to protect yourself (aspergillosis patients)

If you receive wood that:

  • smells musty,

  • has surface mould,

  • or shows green/black spots,

…it is best not to bring it indoors until cleaned.

✔ Immediately unwrap outdoors

Plastic wrapping traps mould spores.

✔ Keep well away from ventilation intakes, windows, or living areas

This avoids airborne spores entering the home.

✔ If mould is visible — return it

You have the right to reject mouldy timber.

✔ If keeping it, clean outdoors with PPE

Use:

  • gloves

  • FFP3 mask

  • borax solution (borax + hot water)
    to remove early surface mould.

Never sand mould indoors — sanding releases spores.

⭐ Simple Diagram: Correct Way to Store Wood to Prevent Mould

Correct storage includes:

  • boards stacked with spacers between them (“sticker stacked”),

  • raised on bearers above the ground,

  • stored under a roof with airflow on all sides,

  • NEVER wrapped in sealed plastic,

  • ends exposed to allow moisture to escape.

This method is cheap, simple, and prevents mould without needing expensive kiln drying.

⭐ Summary for Aspergillosis Patients

Rough-cut wood should not arrive mouldy.
Mould growth usually means it was:

  • stacked badly,

  • stored wet,

  • wrapped in plastic,

  • or shipped before drying.

For people with aspergillosis, ABPA, bronchiectasis or severe asthma, mould spores can trigger symptoms — so it’s completely reasonable to:

  • refuse mouldy timber,

  • request proper handling,

  • or ask the supplier to follow UK best practice.

by GAtherton

⚠️ Flu Season Warning: UK Flu Cases Are Now Surging — Dominated by a Drifted H3N2 Strain

The UK flu season has begun much earlier and much faster than usual, and cases are now surging across the country. The UK Health Security Agency (UKHSA) confirms that the dominant strain this year is a drifted influenza A(H3N2) variant (sub-clade K). This strain now accounts for the vast majority of flu cases in people tested.

🔥 Why this flu season is different

  • Almost all flu cases are influenza A, and around 84% of typed cases are H3N2.
    This pattern is consistent across community, GP and hospital surveillance.

  • The H3N2 strain circulating is genetically drifted, meaning it has evolved away somewhat from the reference vaccine strain.
    UKHSA has publicly confirmed this drift.

  • This increases the risk of infection spreading rapidly — which is exactly what is happening now.

🛡️ Does the flu vaccine still work?

Yes — despite the drift, UKHSA reports that the 2025–26 flu vaccine still provides important protection, including:

  • ~70–75% effectiveness in children

  • ~30–40% effectiveness in adults

This means vaccination dramatically reduces severity, even if it does not fully prevent infection.

⚠️ Why this matters for people with lung conditions

If you have:

  • ABPA (Allergic Bronchopulmonary Aspergillosis)

  • Bronchiectasis

  • Asthma

  • Chronic lung disease
    …you are at higher risk of:

  • pneumonia

  • severe chest infections

  • hospitalisation

  • long recovery times

H3N2 seasons are historically worse for adults and people with underlying respiratory disease.

🔺 What you should do now

1. Get vaccinated immediately

If you haven’t had your flu jab yet, do not wait.
The season is already surging and accelerating earlier than usual.

2. Be extremely cautious in high-risk environments

  • Schools

  • Public transport

  • Healthcare settings

  • Large indoor gatherings

  • Poorly ventilated rooms

3. Use winter protection behaviours

  • Ventilate indoor spaces

  • Consider wearing a mask in crowded indoor areas

  • Wash hands frequently

  • Avoid contact with people who are unwell

4. If you become ill — act fast

For anyone with ABPA, bronchiectasis or asthma:

  • A sudden fever

  • A sharp rise in cough

  • Change in sputum

  • Chest tightness

  • Breathing changes

…should be treated as early warning signs.
Contact your GP or respiratory team quickly, as secondary pneumonia is more likely in H3N2 seasons.

Summary

Flu is now surging across the UK, driven by a drifted H3N2 strain, and people with underlying lung disease should take this season particularly seriously.
Vaccination remains strongly protective, but additional precautions are vital during this rapid upswing in cases.

by GAtherton

Why Exposure to Young Children Can Increase Illness in Aspergillosis, ABPA, and Bronchiectasis — and How to Track Viral Outbreaks

Many patients with Allergic Bronchopulmonary Aspergillosis (ABPA), aspergillus-related asthma, or bronchiectasis notice that they become ill far more often when spending time around younger children. This applies whether you work with them, live with them, or spend time with grandchildren or family groups. Here’s why it happens, what other patients experience, and how to monitor viral outbreaks so you can protect yourself.

Why Young Children Increase Illness Risk

1. Young children spread far more respiratory infections

Children under 11:

  • Carry more colds, viruses, and respiratory bugs

  • Shed viruses for longer periods

  • Have high viral loads

  • Are still learning hygiene habits

  • Spend a lot of time in close physical contact with adults

Even small viral infections can cause major lung flares in ABPA and bronchiectasis.

2. Viral infections trigger flare-ups, exacerbations, and pneumonia

With:

  • Bronchiectasis → mucus doesn’t clear properly, so infections “stick”

  • ABPA → airways are inflamed, reactive, and mucus-filled

  • Asthma → viruses are the most common exacerbation trigger

A simple cold in a child can turn into:

  • Fever

  • Chest infection

  • Need for antibiotics

  • Pneumonia

  • Weeks of recovery

This pattern is extremely common.

3. Children spread viruses even when only mildly ill

Some viruses (RSV, adenovirus, flu) spread before symptoms, or for many days after a child appears well.

Adults with lung conditions may experience far more severe symptoms from these same infections.

4. Any indoor, close-contact time increases risk

This includes:

  • Teaching music or classroom work

  • Caring for grandchildren

  • Sitting in cars together

  • Birthday parties, playgroups, soft play

  • Family gatherings

  • Living in the same household

Even short exposures can be enough in winter months.

What Other Aspergillosis Patients Report

Across support groups and clinics:

  • Many patients stay well until grandchildren reach nursery/school age.

  • Switching from high school to primary/elementary teaching often leads to repeated infections.

  • People frequently report more pneumonias in winter when around young children.

This is very common and not your fault.

How to Reduce Risk (Realistically)

1. Improve ventilation

  • Open windows/doors during visits or lessons

  • Use a HEPA air purifier at home or work

  • Avoid long stays in small rooms

2. Control exposure without avoiding children

Shorter visits with good ventilation are safer than long indoor contact.

3. Keep up with airway clearance routines

Vital for preventing infections from settling.

4. Mask during periods of high virus circulation

Especially when RSV, flu, COVID, or “winter bugs” are rising.

5. Stay vaccinated

Flu, pneumococcal, COVID (if eligible), and pertussis if around infants.

6. Get medical review if you're repeatedly unwell

Your team may consider:

  • Prophylactic antibiotics

  • Nebulised saline

  • Optimising inhalers/biologics

  • Checking ABPA control

7. Use Occupational Health if exposure is workplace-related

Ask for:

  • Teaching older groups

  • Ventilation improvements

  • Reduced winter exposure

Where to Get Reliable Information on Viral Outbreaks

Tracking viral activity can help you plan safer weeks and reduce the chance of flare-ups.

1. UK Health Security Agency (UKHSA)

Weekly reports on:

  • Flu

  • COVID

  • RSV

  • Measles and other outbreaks

  • Regional activity levels

Best official national overview. Link

2. GOV.UK Infectious Disease Reports

Lists:

  • Confirmed outbreaks

  • Public health warnings

  • School/nursery clusters

  • Localised alerts

3. Local NHS Trust or ICB Websites

Many publish:

  • Weekly respiratory dashboards

  • Local flu/RSV alerts

  • Outbreak notices for schools and care settings

(Example: Greater Manchester ICB has regular respiratory activity updates.)

4. GP Surgeries & NHS App Alerts

GPs can push:

  • Local viral alerts

  • Flu surges

  • Measles/strep notifications

Often one of the earliest local signals.

5. School/Nursery Letters and Newsletters

Schools must notify families about:

  • Flu/strep outbreaks

  • High absence levels

  • Confirmed clusters

Very useful if you work with or spend time around children.

6. Zoe Health Study App

Crowd-sourced, real-time data on:

  • Colds

  • Flu-like illness

  • COVID

  • Regional spikes

Good for early warning.

7. Local Council Public Health

Check:
[Your council] + “Public Health”
They often post:

  • Local outbreak alerts

  • Enhanced infection-control notices

  • Community virus trends

8. NHS 111 Online Data

Shows real-time spikes in:

  • Cough

  • Fever

  • Chest infections

  • Sore throat or strep symptoms

A useful snapshot of local trends.

Key Message

Yes — any exposure to young children can raise infection risk when you have aspergillosis, ABPA, or bronchiectasis.
Tracking viral outbreaks helps you plan safer contact, adjust your activities, and reduce the chance of pneumonia or flare-ups.

Resources

Here are direct links to trusted resources you can use to monitor viral outbreaks and infection risk (especially helpful for those with ABPA, bronchiectasis, asthma, and other lung conditions):

by GAtherton

💙 The NHS Is Changing: What “Value-Based Healthcare” Means for People with Aspergillosis

The NHS is beginning to look not just at how many people it treats, but how well those treatments work — and whether every pound spent makes the biggest difference to patients’ lives.
This idea is called value-based healthcare (VBHC).

🧭 What “value” means

In simple terms, value =

Better health and quality of life for patients ➗ the resources and effort used to achieve it.

It’s not about cutting care.
It’s about making sure time, money, and medicines are used where they bring the greatest benefit — especially for people with long-term or complex conditions like aspergillosis.

⚙️ From “productivity” to “value”

Until now, the NHS has mostly measured productivity — how many people are seen, how many tests or treatments are delivered, and how quickly.

That approach works for short-term or simple care (like hip replacements or cataract surgery), but it doesn’t tell the full story for complex, long-term conditions such as aspergillosis, where the real goal is to stay well, avoid hospital admissions, and maintain a good quality of life.

So, over the next few years, these older productivity measures will gradually be replaced or balanced with value-based measures that ask:

“Did this care actually help patients live better and longer — and was it a good use of NHS resources?”

This means success will be judged more on outcomes and experience than on numbers and speed.

🌿 Why this matters for people with aspergillosis

Aspergillosis, whether Allergic Bronchopulmonary Aspergillosis (ABPA) or Chronic Pulmonary Aspergillosis (CPA), is often complicated and different for every patient.
Traditional NHS targets — such as waiting times or the number of appointments — don’t always show whether patients are breathing easier, feeling stronger, or coping better at home.

Value-based care changes that by focusing on:

  • Real health outcomes – fewer flare-ups, better lung function, reduced fatigue

  • Patient experience – how well care fits your needs, and how supported you feel

  • Sensible use of treatments – balancing benefit, side effects, and cost

  • Joined-up care – making sure specialists, GPs, and community teams work together smoothly

🏥 How the National Aspergillosis Centre (NAC) fits in

The National Aspergillosis Centre (NAC) already works in a value-based way:

  • It tracks outcomes such as infection control, hospital admissions, and steroid use

  • It listens to patients through groups, surveys, and education sessions

  • It combines research, expert treatment, and patient partnership to improve care

  • It shares learning with hospitals across the UK

As the NHS moves further toward value-based care, NAC’s approach — measuring what really matters to patients — is exactly the kind of model the health service wants to grow.

🔄 What might change over the next few years

You may start to notice:

  • More focus on your experience and progress: you might be asked to fill in short questionnaires about symptoms and quality of life (called Patient-Reported Outcome Measures or PROMs).

  • Better coordination between hospital, GP, and community teams — digital health records will help your care stay connected.

  • New measures of success: NAC may report things like “flare-ups prevented” or “improvement in wellbeing” rather than only how many people were seen.

  • More evidence about what works: shared data will help identify which treatments or combinations give the most benefit.

⚠️ What it does not mean

  • It doesn’t mean fewer services or reduced access for people with complex lung disease.

  • Rare conditions like aspergillosis will continue to need specialist national centres because they provide expert care that general services can’t.

  • The goal is to show that centres like NAC deliver high value — preventing complications, reducing hospital stays, and improving lives.

💬 What you can do

  • Give feedback about your health and care — this helps measure real outcomes.

  • Take part in surveys or PROMs if asked — these are how value is proven.

  • Stay involved in patient groups and discussions — your voice helps shape what “value” means for people living with aspergillosis.

🌱 In summary

The NHS is moving from counting treatments to counting outcomes.
For people with aspergillosis, that means care that’s more personalised, joined-up, and focused on what really matters — your health, comfort, and quality of life.

The National Aspergillosis Centre is well placed to lead this change and to show how specialist, patient-centred care can deliver real value for people with complex lung disease.

by GAtherton

🌬️ Breathing Easier: Keeping Your Air Clean at Home, Work and When Travelling

People with lung conditions such as aspergillosis, asthma, or bronchiectasis often find their symptoms worsen in certain environments — especially where the air feels dusty, damp, or polluted.
The good news is that there are simple, practical steps you can take to control your surroundings, reduce flare-ups, and make your home a safer, healthier place to breathe.

🏠 At Home

Keep It Dry and Well-Ventilated

  • Tackle damp and leaks early. Mould thrives in moist places — even hidden behind furniture or under wallpaper.

  • Trust your nose. If something smells damp, it probably is. A musty smell means moisture is trapped somewhere — investigate and dry it before mould can grow.

  • Ventilate daily. Open windows when outdoor air is clean, or use extractor fans in kitchens and bathrooms.

  • Prevent moisture spreading. When showering, cooking, or drying laundry, close doors to other rooms so steam and humidity don’t spread through the house.

    • Run the extractor fan during and for at least 15–20 minutes afterwards, or until humidity drops.

    • Short humidity spikes are normal. It’s common for relative humidity (RH) to rise above 60% during cooking, showering, or drying clothes — what matters is that it returns below 60% quickly once fans or windows are open.

    • If condensation lingers or humidity stays high for more than 30–40 minutes, increase ventilation or use a dehumidifier.

  • Use humidity-sensing extractor fans. These switch on automatically when humidity rises and off when it falls.

    • Choose one with a humidistat and timer, vented directly outdoors (not into a loft or wall cavity).

    • Clean the fan cover and check filters every few months.

  • Dry laundry safely. Use a vented or condenser tumble dryer and empty or clean filters and tanks regularly.

    • Avoid drying clothes on radiators unless you’re using a dehumidifier or have good airflow.

  • Monitor humidity. Use a small digital hygrometer to track RH in different rooms.

    • Aim for 40–60% most of the time — this discourages mould and keeps air comfortable.

    • Above 60% for long periods encourages condensation and spores; below 35% can dry and irritate airways.

  • Use the right size dehumidifier.

    • Check the model’s rated room area (m²) or litres per day extraction rate.

    • A compact unit may cope with a small bedroom or bathroom but not a whole flat or open-plan area.

    • Keep doors closed while it’s running for best results, and empty and clean the water tank regularly to prevent bacterial build-up.

Control Dust and Irritants

  • Vacuum regularly with a HEPA-filtered vacuum cleaner.

  • Use microfibre cloths for dusting rather than dry dusters that stir particles into the air.

  • Avoid strongly fragranced cleaning products, candles, incense, and air fresheners — they release fine particles and chemicals that irritate sensitive lungs.

  • Choose low-VOC (low-odour) paints and furnishings when redecorating.

Keep Air Clean

  • If you live near traffic or building work, keep windows closed during busy times and ventilate later.

  • A room air purifier with a true HEPA filter can remove dust, pollen, and fungal spores effectively.

  • Choose the right size for your room.

    • Check the purifier’s Clean Air Delivery Rate (CADR) or maximum room coverage and ensure it matches or slightly exceeds your room size.

    • A small desktop purifier won’t clean a large living room or bedroom effectively.

    • For open-plan or high-ceiling spaces, you may need more than one unit.

  • Maintain it properly:

    • Replace or clean filters exactly as the manufacturer recommends (usually every 6–12 months).

    • Never wash or vacuum a disposable HEPA filter unless the manual allows it.

    • A clogged or undersized filter won’t clean air effectively and may re-release particles.

🌤️ Knowing When the Outside Air Is Clean — and How to Filter It Indoors

1. Check Air Quality Before Ventilating

It isn’t always obvious when outdoor air is safe to bring inside.
Modern air-quality data helps you choose the best times to open windows or run fans.

How to check:

  • Use free apps such as Air Quality Index (AQI) UK, Breezometer, Plume Labs, or AirVisual.

  • Visit DEFRA’s UK Air Information or check BBC Weather → Air Quality.

  • Look for PM2.5 (fine particles) and NO₂ (traffic pollution) levels — these are key irritants for sensitive lungs.

  • “Good” or “Low” readings mean it’s a good time to ventilate or air rooms.

  • Avoid opening windows near busy roads during rush hour or when pollution alerts are issued.

💡 Tip: Air quality is often better early in the morning or late in the evening when traffic and heat are lower.

2. Filter the Air as It Comes In

If you live near roads, building work, or farmland, you can reduce what enters while keeping ventilation safe:

🪟 Window Vent Filters

  • Many modern trickle vents can take fine mesh or electrostatic filters to trap pollen, dust, and spores.

  • Replace or wash filters regularly — clogged filters restrict airflow.

🌀 Filtered Ventilation Systems

  • MVHR systems (Mechanical Ventilation with Heat Recovery) pull in outdoor air, filter it, and expel stale indoor air — great for energy-efficient or damp-prone homes.

    • They help control humidity and filter pollutants.

    • Filters must be cleaned or replaced every few months.

  • Positive Input Ventilation (PIV) systems bring in filtered air gently from a roof or external vent, improving airflow and reducing condensation.

🧺 DIY Improvements

  • Clip-on intake filters can fit over some wall vents or fan inlets.

  • Use a portable HEPA purifier placed near an open window to “clean” incoming air as it circulates.

  • Keep window ledges, vent grilles, and trickle vents dust-free — they collect spores over time.

3. Balance Fresh Air and Safety

It’s important not to seal up a home completely — stale, humid air encourages mould.
The goal is controlled ventilation:

  • Ventilate when outdoor air is cleanest and driest.

  • Keep extractor fans running during steamy activities.

  • When outdoor air quality is poor, use purifiers and dehumidifiers indoors until it improves.

4. Low-Cost Monitoring at Home

You can buy small indoor/outdoor air-quality monitors that track PM2.5, temperature, and humidity.
These help you:

  • Spot pollution drifting indoors (from traffic, wood smoke, etc.).

  • Choose the best times to ventilate.

  • See how quickly humidity or particles fall after cooking or cleaning.

🌱 Summary

What to Do Why It Helps
Check local air-quality apps before opening windows Avoids letting polluted air inside
Ventilate during low-pollution hours Brings in cleaner, fresher air
Fit filters to vents or use MVHR/PIV systems Reduces dust and spores from incoming air
Clean vents, trickle filters, and window frames regularly Prevents build-up of trapped dust
Use a portable HEPA purifier near open windows Cleans incoming air in real time

🧽 Dealing with Mould and Dust Safely

Even in well-kept homes, mould and dust can build up in damp weather or hidden corners. If you see black or green patches, or notice a musty smell, act promptly — but take care to protect your lungs.

⚠️ Before You Start

  • Protect yourself: wear a well-fitted FFP2 or N95 mask, gloves, and, if possible, eye protection.

  • Avoid dry brushing or vacuuming visible mould — this can spread spores into the air.

  • Keep the area well ventilated but close doors to other rooms so spores don’t travel.

  • If the mould covers more than 1 square metre, keeps returning, or is linked to a leak, ask your landlord or council for professional help.

🧴 Cleaning Small Areas of Mould

  1. Wipe gently — don’t scrape.
    Use disposable cloths or ones you can boil-wash later. Avoid wire brushes.

  2. Use mild cleaning solutions:

    • Mix a few drops of washing-up liquid in warm water, or

    • Use a dilute bleach solution (1 part thin bleach to 9 parts water) on tiles or uPVC — ventilate well and never mix bleach with other cleaners, or

    • Try a specialist anti-fungal cleaner for painted or porous surfaces.

  3. Dry the area thoroughly.
    Use ventilation or a dehumidifier; mould will return if the surface stays damp.

  4. Dispose of cloths and gloves in a sealed bag. Wash hands well afterwards.

🧹 Managing Dust and Allergens

  • Vacuum at least twice weekly with a HEPA-filtered cleaner.

  • Dust with a damp microfibre cloth, not a feather duster.

  • Wash bedding and soft furnishings regularly at 60 °C if the fabric allows.

  • Avoid clutter that collects dust (papers, books, soft toys).

  • Keep humidity within 40–60% and fix damp quickly.

🌱 Preventing Mould and Dust Returning

Action Why It Helps
Find and fix leaks or condensation sources Mould needs moisture to grow
Ventilate kitchens, bathrooms, and drying areas Removes steam before it spreads
Use humidity-sensing fans or dehumidifiers Keeps humidity in a safe range
Maintain a steady indoor temperature Reduces cold surfaces and condensation
Close doors during steamy activities Stops damp air moving into other rooms
Replace or clean HEPA filters regularly Maintains air-cleaning performance
Check behind furniture and on windowsills Finds hidden damp early
Repaint cleaned areas with mould-resistant paint Discourages regrowth

🚫 What Not to Do

  • Don’t paint over mould — it will grow back.

  • Don’t use strong chemicals or foggers in small spaces — they can irritate lungs.

  • Don’t use steam cleaners on large mould patches — they can spread spores.

  • Don’t ignore damp smells — they always mean hidden moisture somewhere.

💼 At Work

  • Ask about ventilation and report any damp, leaks, or condensation.

  • Keep your workspace tidy and free of dust-collecting clutter.

  • If cleaning sprays or perfumes cause coughing, discuss adjustments with your manager or occupational health team.

✈️ When Travelling

  • Check air-quality forecasts before travelling and avoid outdoor activity on high-pollution or pollen days.

  • Choose clean, dry accommodation — avoid musty or damp-smelling rooms.

  • Pack a small hygrometer or travel dehumidifier for longer stays.

  • Use a well-fitted FFP2 or N95 mask in crowded or polluted environments.

  • Stay hydrated and pace activities in humid or hot weather.

🩺 Listen to Your Body

Keep a short diary of when and where your symptoms flare up, along with temperature, humidity, or smells you notice. Patterns often reveal your personal triggers.

🌱 Key Points

Good Practice Why It Matters
Keep home dry, clean, and ventilated Reduces mould and spore exposure
If it smells damp, it probably is Early warning of hidden moisture
Humidity above 60% after showering or cooking is normal — keep it short Prevents condensation and mould
Close doors while cooking, showering, or drying laundry Stops moisture spreading
Use humidity-sensing extractor fans Clears steam automatically
Monitor humidity (40–60%) Keeps air comfortable and discourages spores
Match HEPA filters and dehumidifiers to room size Ensures real air-cleaning and drying effect
Maintain and replace filters regularly Keeps air safe and fresh
Check outside air quality before opening windows Avoids bringing pollution indoors
Filter incoming air with vents or MVHR/PIV systems Keeps dust and spores out
Clean small mould patches safely with mild detergent Removes spores without irritation
Fix leaks, repaint with mould-resistant paint Prevents regrowth
Avoid strong scents and aerosols Reduces airway irritation
Plan travel around clean-air days Lowers risk of flares and infections

💬 Final Thought

You can’t control every environment — but small, steady habits make a big difference.
If something smells damp, it probably is. Deal with it early, clean gently, dry thoroughly, and keep air moving.
Short humidity spikes after showering or cooking are normal — just make sure they don’t linger.
Choose purifiers and dehumidifiers that are the right size for your rooms, and maintain them well.
Check outdoor air quality before airing your home, and use filters to keep what’s good while blocking what’s not.
A dry, clean, well-ventilated home gives your lungs the best chance to stay healthy every day — wherever you are.

by GAtherton

🦠 Latest Aspergillosis Updates (Weeks 45 & 46)

Over the past two weeks, several new studies and reports have deepened understanding of aspergillosis – the group of lung and sinus infections or allergic diseases caused by Aspergillus moulds.
They cover new national guidance, emerging risk groups, drug interactions, and new ideas for diagnosis.

🔹 1. National Best-Practice Update (BSMM 2025)

What’s new:
The British Society for Medical Mycology (BSMM) has released its 2025 recommendations for diagnosing serious fungal diseases such as aspergillosis.
The update emphasises:

  • using standardised blood and imaging tests across hospitals,

  • improving access to specialist mycology laboratories,

  • faster recognition in people with chronic lung disease, transplant, or immune suppression.

Why it matters:
Patients should receive the same high-quality diagnostic work-up wherever they are treated in the UK, reducing delays and missed cases.

🔹 2. Drug Interaction: Posaconazole + Olorofim

What’s new:
Researchers discovered that combining posaconazole (an existing antifungal) with olorofim (a new one still in trials) can cancel out each other’s effect in laboratory and animal tests.

Why it matters:
Doctors will avoid using these two together until proper studies confirm safety.
This ensures that new antifungal drugs are introduced carefully and responsibly, not just because they’re newer.

🔹 3. Invasive Aspergillosis in Non-Neutropenic Patients

What’s new:
Traditionally, invasive pulmonary aspergillosis (IPA) affected people with very low white-cell counts, such as cancer or transplant patients.
A new review shows that people without immune deficiency, including those in ICU, with COPD, or taking steroids, can also develop life-threatening infection.

Why it matters:
Clinicians are being urged to consider aspergillosis sooner when patients with chronic lung disease suddenly deteriorate or fail to respond to antibiotics.

🔹 4. Severe Case in Acute Liver Failure

What’s new:
A case report describes aspergillosis spreading in a patient with acute liver failure, detected by endoscopy rather than usual lung imaging.

Why it matters:
Highlights that aspergillosis can start outside the lungs and that liver-failure patients may have hidden fungal infection even without classic risk factors.

🔹 5. Post-Partum Aspergillus flavus Infection

What’s new:
A rare infection occurred soon after childbirth, caused by Aspergillus flavus rather than the usual A. fumigatus.

Why it matters:
Shows that pregnancy and recovery can temporarily lower resistance to infection.
Unusual breathlessness or fever after delivery deserves careful investigation.

🔹 6. Immune Markers for Chronic and Allergic Forms (CPA and ABPA)

What’s new:
Researchers have mapped immune-system signals (biomarkers) that could help diagnose or monitor chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) when scans or sputum tests are inconclusive.

Why it matters:
These blood-based tests could make diagnosis faster, less invasive, and more consistent – especially where bronchoscopy isn’t possible.

🧩 The Big Picture

Theme Main message Take-home insight
National guidance UK best-practice standardised Earlier, fairer diagnosis nationwide
Antifungal drugs New combinations must be tested Avoid mixing old + new agents unsafely
Expanding risk groups COPD, ICU, steroid use, liver disease Aspergillosis not limited to cancer patients
Case lessons Post-partum and liver-failure infections Stay alert to rare but serious forms
Chronic & allergic disease New immune biomarkers Blood tests could support follow-up

👥 What this means for you

  • Patients: if you have asthma, COPD, bronchiectasis, or another chronic lung problem and suddenly feel worse or don’t improve on antibiotics, ask whether aspergillosis has been considered.
    Modern tests can often detect it from a blood sample.

  • GPs and non-specialist staff: awareness is key. These studies stress early suspicion, use of mycology testing, and following the BSMM 2025 guidance for timely referral.

  • Researchers: note the priority areas – drug-interaction monitoring, immune-marker validation, and cross-disciplinary education between hepatology, ICU, obstetrics, and respiratory medicine.

🔗 Further reading

  • BSMM 2025 Best Practice Recommendations — Lancet Infect Dis (2025)

  • Posaconazole–Olorofim Interaction — J Antimicrob Chemother (2025)

  • IPA in Non-Neutropenic Patients — Clin Infect Dis (2025)

  • Immune Markers in CPA & ABPA — Front Immunol (2025)
    Full links: 1 | 3 | 4 | 6

by GAtherton

🧬 What IgE Is and Why It Matters

IgE is a type of antibody your immune system makes when it reacts to something it sees as harmful — such as pollen, mould, pet dander, or certain foods.
In people with allergic or fungal lung disease, IgE can rise sharply because the body’s immune system is over-reacting.

High IgE isn’t dangerous on its own, but it shows that your immune system is “switched on” and inflamed. The goal is to calm that inflammation and reduce exposure to what’s triggering it — not simply to force the number down.

✅ Best Practices for Reducing IgE Levels

1️⃣ Identify and Avoid Triggers

Reducing exposure is the first and most effective step.

  • Allergens: dust mites, moulds (especially Aspergillus), pollens, pets.

  • Environmental irritants: cigarette smoke, air pollution, strong odours, damp housing.

  • Use HEPA filters, good ventilation, and address damp or mould at home.

  • In ABPA, avoiding heavy exposure to fungal spores (e.g. gardening compost, rotting leaves, renovation dust) is particularly important.

2️⃣ Control Inflammation and Allergic Response

Because IgE is a marker of allergic inflammation, treatment focuses on calming the immune system:

  • Corticosteroids (oral or inhaled) can suppress inflammation and lower IgE over time.

  • Biologic therapies such as:

    • Omalizumab (Xolair) – directly targets IgE and lowers levels in allergic asthma or ABPA.

    • Mepolizumab, Benralizumab, or Dupilumab – reduce eosinophil-driven inflammation and may indirectly lower IgE.

    • Choice depends on your disease type and blood test results.

  • Antifungal therapy (e.g. itraconazole, voriconazole, posaconazole) can help reduce fungal load in ABPA and often leads to gradual IgE reduction as the reaction settles.

3️⃣ Manage Asthma or Lung Disease Well

Stable lungs mean fewer immune flares and less IgE activity:

  • Use prescribed inhalers regularly (preventers, not just relievers).

  • Follow your asthma or CPA action plan.

  • Attend regular reviews with your respiratory team.

  • Report any new symptoms such as increased cough, wheeze, or mucus plugs early.

4️⃣ Support Overall Immune Balance

Simple lifestyle steps can also help keep inflammation low:

  • Eat a balanced diet rich in fruit, vegetables, and omega-3 fats.

  • Sleep well and manage stress (both can worsen inflammation).

  • Avoid smoking or vaping.

  • Keep vaccinations (e.g. flu, COVID, pneumococcal) up to date.

📊 Interpreting IgE Levels

  • IgE levels naturally fluctuate and may take weeks or months to fall after treatment.

  • Doctors often look at the trend (rising or falling) rather than one number.

  • In ABPA, a fall of 35–50 % from baseline after treatment usually shows improvement.

  • It’s also possible to feel better while IgE remains high — so the result must always be interpreted alongside symptoms and scans.

🚫 What Not to Do

  • Don’t chase a “perfect” IgE number — focus on feeling better and reducing inflammation.

  • Don’t stop steroids or antifungals suddenly unless advised by medical doctor, as this can cause a rebound flare.

  • Don’t rely on supplements or “immune boosters” that claim to lower IgE — none are proven to help and some may worsen allergies.

🩺 In Summary

Goal Best Approach
Reduce IgE triggers Avoid mould, dust, smoke, allergens
Calm inflammation Steroids or biologics under medical supervision
Treat underlying disease Antifungals for ABPA/CPA, good asthma control
Support immune balance Healthy lifestyle, good sleep, stress reduction

🌱 Key Message

You can’t “switch off” IgE completely — it’s part of your immune defence.
The aim is to reduce unnecessary immune activation, keep symptoms stable, and prevent lung damage.
With the right mix of trigger avoidance, anti-inflammatory treatment, and regular monitoring, IgE levels usually fall gradually as the condition improves.

by GAtherton

🧪 Why New Antifungal Trials Start with Invasive Aspergillosis

When you hear about promising new antifungal medicines such as Olorofim or Fosmanogepix, you may wonder why the first studies always seem to involve people with invasive aspergillosis — not those with chronic pulmonary aspergillosis (CPA) or allergic bronchopulmonary aspergillosis (ABPA).

It might seem unfair, especially when chronic forms of aspergillosis are so common and long-lasting.
But there are good reasons why research has to begin with invasive disease.

Here’s how it works — and why it’s still good news for everyone living with aspergillosis.

⚠️ 1. Invasive Aspergillosis Is the Most Dangerous Form

Invasive aspergillosis happens when Aspergillus spreads deep into the lungs or bloodstream, usually in people with a very weak immune system — for example, after chemotherapy, transplant, or high-dose steroid use.

Without prompt treatment, it can be fatal within days or weeks.
Because it is so serious, regulators such as the MHRA (UK), EMA (Europe) and FDA (USA) allow new drugs for invasive infections to be tested and reviewed much faster than they would for less urgent diseases.

This approach means that if a new antifungal proves helpful and safe, it can reach patients in greatest need more quickly — often saving lives while also building the data needed for later studies in other conditions.

📈 2. It’s Easier to Measure Whether the Drug Works

For invasive disease, the goal is very clear:

The infection either clears up, or it doesn’t.

That makes the results of a study straightforward to interpret.

With chronic or allergic aspergillosis, improvement takes much longer to measure:

  • Scans may take months to show change,

  • Symptoms can fluctuate naturally, and

  • Other lung problems (like COPD or bronchiectasis) can confuse the results.

So trials in chronic disease need larger patient numbers and longer follow-up, which are expensive and take years. Starting with invasive aspergillosis lets researchers get the essential safety and efficacy answers first.

🧾 3. The Regulatory Framework Focuses on Invasive Disease

Drug-approval rules for antifungals were originally designed for the most life-threatening infections.
Official guidance documents — from the EMA, FDA and others — describe exactly how to test new drugs for invasive fungal infections, but there are no formal international standards yet for chronic or allergic aspergillosis.

That means developers start where the rules are clear — and then adapt once regulators, researchers, and clinicians agree on what a “successful outcome” looks like for chronic disease.

⚖️ 4. Safety and Ethics Come First

When a new antifungal is in early testing, doctors don’t yet know all its side-effects or how it behaves during long-term use.
For ethical reasons, it’s safer to begin in patients with very few other treatment options, where the potential benefit outweighs the risk.

As safety data builds up — including how the medicine interacts with other drugs — it becomes safer to test in people with more stable chronic conditions such as CPA.

🩺 5. Once Proven Safe, Use Can Expand

Once a drug like Olorofim or Fosmanogepix:

  • works well in invasive aspergillosis,

  • has solid safety data, and

  • earns its first licence,

the manufacturer and research partners (such as the National Aspergillosis Centre) can propose new studies in CPA or other forms of aspergillosis.

By then, regulators already know the drug’s risk profile, dosing, and monitoring needs — so further approvals for chronic disease can move faster.

🧩 In Summary

Reason Why invasive aspergillosis comes first
Urgency It’s the most life-threatening form, so ethics allow faster testing
Clear results Success or failure can be measured more easily
Existing standards Regulatory guidance already written for invasive disease
Safety first Starts with people who have no other treatment
Builds the base Data from invasive disease supports later CPA/ABPA trials

🌱 Looking Ahead

Starting with invasive aspergillosis is a gateway, not a dead-end.
Every study adds vital knowledge about how these new antifungals work, how safe they are, and which patients might benefit most.

Once enough evidence exists, clinical trials can — and almost certainly will — expand to include chronic pulmonary aspergillosis (CPA) and possibly even allergic forms of the disease.

So while the research focus may begin with the most critical cases, the progress made there ultimately helps everyone living with aspergillosis.

by GAtherton